Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
2012/05/23 by Yanyan Zhu, Bhavik J. Pandya, Hyon K. Choi · 27 citations
Medicine · Nursing · #Gout, Hyperuricemia, Uric Acid #Thyroid Disorders and Treatments #Sodium Intake and Health
paper · pdf · doi:10.1016/j.amjmed.2011.09.033
Cited by
- The Molecular Physiology of Uric Acid Homeostasis
- Gout-Related Medication Use After Initiating Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies
- Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. [europepmc]
- AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages. [europepmc]
- A review of uric acid, crystal deposition disease, and gout. [europepmc]
- Gout and the risk of Alzheimer's disease: a population-based, BMI-matched cohort study. [europepmc]
- Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. [europepmc]
- Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. [europepmc]
- Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid. [europepmc]
- The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. [europepmc]
- Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study. [europepmc]
- Management of Gout and Hyperuricemia in CKD. [europepmc]
- Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases. [europepmc]
- The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years. [europepmc]
- Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout. [europepmc]
- Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. [europepmc]
- Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study. [europepmc]
- Physiology of Hyperuricemia and Urate-Lowering Treatments. [europepmc]
- Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts. [europepmc]
- Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. [europepmc]
- Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. [europepmc]
- The role of diet in hyperuricemia and gout. [europepmc]
- Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization. [europepmc]
- Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment. [europepmc]
- Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights. [europepmc]
- Uric Acid and Chronic Kidney Disease: Still More to Do. [europepmc]
- Global, regional, and national burden of gout, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. [europepmc]